406 related articles for article (PubMed ID: 26083485)
1. How to test the effect of aspirin and clopidogrel in patients on dual antiplatelet therapy?
Bagoly Z; Homoródi N; Kovács EG; Sarkady F; Csiba L; Édes I; Muszbek L
Platelets; 2016; 27(1):59-65. PubMed ID: 26083485
[TBL] [Abstract][Full Text] [Related]
2. Comparison of a new P2Y12 receptor specific platelet aggregation test with other laboratory methods in stroke patients on clopidogrel monotherapy.
Bagoly Z; Sarkady F; Magyar T; Kappelmayer J; Pongrácz E; Csiba L; Muszbek L
PLoS One; 2013; 8(7):e69417. PubMed ID: 23844259
[TBL] [Abstract][Full Text] [Related]
3. The additive antiplatelet action of clopidogrel in patients with coronary artery disease treated with aspirin.
Dropinski J; Jakiela B; Sanak M; Wegrzyn W; Biernat M; Dziedzina S; Plutecka H; Szczeklik A
Thromb Haemost; 2007 Jul; 98(1):201-9. PubMed ID: 17598014
[TBL] [Abstract][Full Text] [Related]
4. Dual antiplatelet response during PCI: VerifyNow P2Y12 predicts myocardial necrosis and thromboxane B2 generation confirms wide variation in aspirin response.
Good RI; McGarrity A; James TE; Miller H; McConnachie A; Goodall AH; Oldroyd KG
Thromb Res; 2015 Jun; 135(6):1140-6. PubMed ID: 25746368
[TBL] [Abstract][Full Text] [Related]
5. Variation in thromboxane B2 concentrations in serum and plasma in patients taking regular aspirin before and after clopidogrel therapy.
Good RI; McGarrity A; Sheehan R; James TE; Miller H; Stephens J; Watkins S; McConnachie A; Goodall AH; Oldroyd KG
Platelets; 2015; 26(1):17-24. PubMed ID: 24433337
[TBL] [Abstract][Full Text] [Related]
6. The effect of clopidogrel, aspirin and both antiplatelet drugs on platelet function in patients with peripheral arterial disease.
Jagroop IA; Matsagas MI; Geroulakos G; Mikhailidis DP
Platelets; 2004 Mar; 15(2):117-25. PubMed ID: 15154604
[TBL] [Abstract][Full Text] [Related]
7. Determination of the prevalence of aspirin and clopidogrel resistances in patients with coronary artery disease by using various platelet-function tests.
Woo KS; Kim BR; Kim JE; Goh RY; Yu LH; Kim MH; Han JY
Korean J Lab Med; 2010 Oct; 30(5):460-8. PubMed ID: 20890076
[TBL] [Abstract][Full Text] [Related]
8. Doubling the clopidogrel dose in patients with reduced responsiveness to the standard dose is associated with a limited effectiveness as evaluated by impedance aggregometry.
Stellbaum C; Ayral Y; Morguet A; Schultheiss HP; Rauch U
Cardiovasc Revasc Med; 2012; 13(3):159-66. PubMed ID: 22503564
[TBL] [Abstract][Full Text] [Related]
9. Response to antiplatelet therapy is independent of endogenous thrombin generation potential.
Gremmel T; Panzer S; Steiner S; Seidinger D; Koppensteiner R; Pabinger I; Kopp CW; Ay C
Thromb Res; 2013 Jul; 132(1):e24-30. PubMed ID: 23623170
[TBL] [Abstract][Full Text] [Related]
10. Preoperative platelet aggregation predicts perioperative blood loss and rethoracotomy for bleeding in patients receiving dual antiplatelet treatment prior to coronary surgery.
Plicner D; Mazur P; Hymczak H; Stoliński J; Litwinowicz R; Drwiła R; Undas A
Thromb Res; 2015 Sep; 136(3):519-25. PubMed ID: 26003782
[TBL] [Abstract][Full Text] [Related]
11. Variable responsiveness to clopidogrel and aspirin among patients with acute coronary syndrome as assessed by platelet function tests.
Shenkman B; Matetzky S; Fefer P; Hod H; Einav Y; Lubetsky A; Varon D; Savion N
Thromb Res; 2008; 122(3):336-45. PubMed ID: 18155752
[TBL] [Abstract][Full Text] [Related]
12. Effect of atorvastatin and pravastatin on platelet inhibition by aspirin and clopidogrel treatment in patients with coronary stent thrombosis.
Wenaweser P; Windecker S; Billinger M; Cook S; Togni M; Meier B; Haeberli A; Hess OM
Am J Cardiol; 2007 Feb; 99(3):353-6. PubMed ID: 17261397
[TBL] [Abstract][Full Text] [Related]
13. Monitoring platelet inhibition after clopidogrel with the VerifyNow-P2Y12(R) rapid analyzer: the VERIfy Thrombosis risk ASsessment (VERITAS) study.
Malinin A; Pokov A; Spergling M; Defranco A; Schwartz K; Schwartz D; Mahmud E; Atar D; Serebruany V
Thromb Res; 2007; 119(3):277-84. PubMed ID: 16563469
[TBL] [Abstract][Full Text] [Related]
14. Effects of polyunsaturated omega-3 fatty acids on responsiveness to dual antiplatelet therapy in patients undergoing percutaneous coronary intervention: the OMEGA-PCI (OMEGA-3 fatty acids after pci to modify responsiveness to dual antiplatelet therapy) study.
Gajos G; Rostoff P; Undas A; Piwowarska W
J Am Coll Cardiol; 2010 Apr; 55(16):1671-8. PubMed ID: 20394870
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of platelet aggregation by prostaglandin E1 (PGE1) in diabetic patients during therapy with clopidogrel and aspirin.
Kreutz RP; Nystrom P; Kreutz Y; Miao J; Kovacs R; Desta Z; Flockhart DA; Jin Y
Platelets; 2013; 24(2):145-50. PubMed ID: 22385219
[TBL] [Abstract][Full Text] [Related]
16. Differential sensitivity and kinetics of response of different ex vivo tests monitoring functional variability of platelet response to clopidogrel.
Bal Dit Sollier C; Berge N; Boval B; Dubar M; Drouet L
Thromb Haemost; 2010 Sep; 104(3):571-81. PubMed ID: 20664906
[TBL] [Abstract][Full Text] [Related]
17. Smoking promotes clopidogrel-mediated platelet inhibition in patients receiving dual antiplatelet therapy.
Gremmel T; Steiner S; Seidinger D; Koppensteiner R; Panzer S; Kopp CW
Thromb Res; 2009 Nov; 124(5):588-91. PubMed ID: 19631365
[TBL] [Abstract][Full Text] [Related]
18. Limited early antiplatelet effect of 300 mg clopidogrel in patients with aspirin therapy undergoing percutaneous coronary interventions.
Lepäntalo A; Virtanen KS; Heikkilä J; Wartiovaara U; Lassila R
Eur Heart J; 2004 Mar; 25(6):476-83. PubMed ID: 15039127
[TBL] [Abstract][Full Text] [Related]
19. Adding cilostazol to dual antiplatelet therapy achieves greater platelet inhibition than high maintenance dose clopidogrel in patients with acute myocardial infarction: Results of the adjunctive cilostazol versus high maintenance dose clopidogrel in patients with AMI (ACCEL-AMI) study.
Jeong YH; Hwang JY; Kim IS; Park Y; Hwang SJ; Lee SW; Kwak CH; Park SW
Circ Cardiovasc Interv; 2010 Feb; 3(1):17-26. PubMed ID: 20118150
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of aspirin and clopidogrel resistance among patients with and without drug-eluting stent thrombosis.
Pinto Slottow TL; Bonello L; Gavini R; Beauzile P; Sushinsky SJ; Scheinowitz M; Kaneshige K; Xue Z; Torguson R; Tantry U; Pichard AD; Satler LF; Suddath WO; Kent K; Gurbel P; Waksman R
Am J Cardiol; 2009 Aug; 104(4):525-30. PubMed ID: 19660606
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]